818.F ZYLOX-TONBRDG.MED.TECH.H1
- Market cap
- EUR 686M
- P/E
- 17.3x
- P/B
- 1.74x
- ROE
- 3.2%
- Dividend yield
- 1.33%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2024.
Is 818.F undervalued?
Graham number818.F trades 15.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ZYLOX-TONBRDG.MED.TECH.H1 fundamental analysis
No fundamental analysis for ZYLOX-TONBRDG.MED.TECH.H1 yet.
ZYLOX-TONBRDG.MED.TECH.H1 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ZYLOX-TONBRDG.MED.TECH.H1
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portf…
Full company profileZYLOX-TONBRDG.MED.TECH.H1 financial statements
ZYLOX-TONBRDG.MED.TECH.H1 annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 178M | 334M | 528M | 782M |
| Gross Profit | 132M | 253M | 385M | 560M |
| Operating Income | -218M | -222M | -144M | 77.1M |
| EBITDA | - | -86.6M | -41.6M | 140M |
| Net Income | -200M | -114M | -78.7M | 100M |
| EPS | -0.60 | -0.34 | -0.25 | 0.32 |
| Balance Sheet | ||||
| Total Assets | 3.25B | 3.25B | 3.38B | 3.45B |
| Total Liabilities | 104M | 160M | 328M | 352M |
| Shareholders' Equity | 3.14B | 3.09B | 3.05B | 3.10B |
| Cash & Short-term Investments | 1.42B | 1.21B | 1.09B | 418M |
| Cash Flow | ||||
| Operating Cash Flow | -116M | -91.3M | 98.4M | 174M |
| Capital Expenditure | 89.6M | 145M | 191M | 191M |
| Free Cash Flow | -206M | -237M | -92.5M | -17.3M |
| Ratios | ||||
| ROE | -6.4% | -3.7% | -2.6% | 3.2% |
| ROA | -6.1% | -3.5% | -2.3% | 2.9% |
| Net Profit Margin | -112.2% | -34.0% | -14.9% | 12.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ZYLOX-TONBRDG.MED.TECH.H1 dividends
- Dividend yield
- 1.33%
- Forward dividend
- 0.03 EUR
- Payout ratio
- -
- Ex-dividend date
- May 27, 2026
Who owns ZYLOX-TONBRDG.MED.TECH.H1
- Insiders 48.07%
- Institutions 32.29%
- Public & others 19.64%
- Shares outstanding 322M
- Free float 176M
ZYLOX-TONBRDG.MED.TECH.H1 company profile
- Company name
- ZYLOX-TONBRDG.MED.TECH.H1
- Ticker
- 818.F
- ISIN
- CNE100004JD2
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,214
- Fiscal year end
- December
- Address
- Zylox-Tonbridge Industrial Park, Hangzhou, China
- Phone
- 86 571 8861 0082
- Website
- zyloxtb.com
About ZYLOX-TONBRDG.MED.TECH.H1
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
ZYLOX-TONBRDG.MED.TECH.H1 management
5- Dr. Zhong Zhao Ph.D.Founder, Chairman & CEO · born 1968
- Mr. Yang XieExecutive Director & Senior Vice President · born 1970
- Dr. Zheng LiExecutive Director & Senior Vice President · born 1978
- Mr. Quanwei YuanCFO & Joint Company Secretary · born 1980
- Ms. Sau In KwanJoint Company Secretary